Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1–ALK fusion: a case report

Overview of attention for article published in Investigational New Drugs, February 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 32 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,770 followers.

My new case report! https://t.co/O55OOYZ4YU

07 Mar 2019

Reply Repost Favourite

Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1-ALK fusion: a case report. https://t.co/K18dUBIX2G

23 Feb 2019

Reply Repost Favourite

Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1-ALK fusion: a case report. #lymphoma #lymsm https://t.co/oNrqp8kVum

23 Feb 2019

Reply Repost Favourite